ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Personalized Medicines In Oncology Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-19Y8538
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Personalized Medicines In Oncology Market Insights Forecast to 2028
BUY CHAPTERS

Global Personalized Medicines In Oncology Market Research Report 2025

Code: QYRE-Auto-19Y8538
Report
June 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Biotheranostics
Illumina Inc
Dna Link
Genomic Health, Inc.(Exact Sciences)
Cypher Genomics(Human Longevity, Inc.)
Life Technologies Corporation(Thermo Fisher Scientific)
Fulgent Genetics
Caris Life Sciences
Ariana Pharma
Abbott Laboratories
Decode Genetics
Exagen Inc

Personalized Medicines In Oncology Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Personalized Medicines In Oncology Market

Personalized Medicines In Oncology Market

The global market for Personalized Medicines In Oncology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Oncology is a type of medicine that refers to the diagnosis, treatment and prevention of different types of cancers like blood cancer, skin cancer, breast cancer, lung cancer and others.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Personalized Medicines In Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Medicines In Oncology.
The Personalized Medicines In Oncology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Personalized Medicines In Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Personalized Medicines In Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Personalized Medicines In Oncology Market Report

Report Metric Details
Report Name Personalized Medicines In Oncology Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
  • Molecular Oncopathology
  • Genome Diagnostics
  • Radiation Therapy
  • Oncology Testing
  • Chemotherapy
  • Others
Segment by Application
  • Research Centers
  • Governmental Institutions
  • Hospitals
  • Clinical Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biotheranostics, Illumina, DNA Link, Genomic Health, Inc.(Exact Sciences), Cypher Genomics(Human Longevity, Inc.), Life Technologies Corporation(Thermo Fisher Scientific), Fulgent Genetics, Caris Life Sciences, Ariana Pharma, Abbott Laboratories, deCODE genetics, Exagen Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Personalized Medicines In Oncology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Personalized Medicines In Oncology Market report?

Ans: The main players in the Personalized Medicines In Oncology Market are Biotheranostics, Illumina, DNA Link, Genomic Health, Inc.(Exact Sciences), Cypher Genomics(Human Longevity, Inc.), Life Technologies Corporation(Thermo Fisher Scientific), Fulgent Genetics, Caris Life Sciences, Ariana Pharma, Abbott Laboratories, deCODE genetics, Exagen Inc

What are the Application segmentation covered in the Personalized Medicines In Oncology Market report?

Ans: The Applications covered in the Personalized Medicines In Oncology Market report are Research Centers, Governmental Institutions, Hospitals, Clinical Centers, Others

What are the Type segmentation covered in the Personalized Medicines In Oncology Market report?

Ans: The Types covered in the Personalized Medicines In Oncology Market report are Molecular Oncopathology, Genome Diagnostics, Radiation Therapy, Oncology Testing, Chemotherapy, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Personalized Medicines In Oncology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Molecular Oncopathology
1.2.3 Genome Diagnostics
1.2.4 Radiation Therapy
1.2.5 Oncology Testing
1.2.6 Chemotherapy
1.2.7 Others
1.3 Market by Application
1.3.1 Global Personalized Medicines In Oncology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Research Centers
1.3.3 Governmental Institutions
1.3.4 Hospitals
1.3.5 Clinical Centers
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Personalized Medicines In Oncology Market Perspective (2020-2031)
2.2 Global Personalized Medicines In Oncology Growth Trends by Region
2.2.1 Global Personalized Medicines In Oncology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Personalized Medicines In Oncology Historic Market Size by Region (2020-2025)
2.2.3 Personalized Medicines In Oncology Forecasted Market Size by Region (2026-2031)
2.3 Personalized Medicines In Oncology Market Dynamics
2.3.1 Personalized Medicines In Oncology Industry Trends
2.3.2 Personalized Medicines In Oncology Market Drivers
2.3.3 Personalized Medicines In Oncology Market Challenges
2.3.4 Personalized Medicines In Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Personalized Medicines In Oncology Players by Revenue
3.1.1 Global Top Personalized Medicines In Oncology Players by Revenue (2020-2025)
3.1.2 Global Personalized Medicines In Oncology Revenue Market Share by Players (2020-2025)
3.2 Global Personalized Medicines In Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Personalized Medicines In Oncology Revenue
3.4 Global Personalized Medicines In Oncology Market Concentration Ratio
3.4.1 Global Personalized Medicines In Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicines In Oncology Revenue in 2024
3.5 Global Key Players of Personalized Medicines In Oncology Head office and Area Served
3.6 Global Key Players of Personalized Medicines In Oncology, Product and Application
3.7 Global Key Players of Personalized Medicines In Oncology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicines In Oncology Breakdown Data by Type
4.1 Global Personalized Medicines In Oncology Historic Market Size by Type (2020-2025)
4.2 Global Personalized Medicines In Oncology Forecasted Market Size by Type (2026-2031)
5 Personalized Medicines In Oncology Breakdown Data by Application
5.1 Global Personalized Medicines In Oncology Historic Market Size by Application (2020-2025)
5.2 Global Personalized Medicines In Oncology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Personalized Medicines In Oncology Market Size (2020-2031)
6.2 North America Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Personalized Medicines In Oncology Market Size by Country (2020-2025)
6.4 North America Personalized Medicines In Oncology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Personalized Medicines In Oncology Market Size (2020-2031)
7.2 Europe Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Personalized Medicines In Oncology Market Size by Country (2020-2025)
7.4 Europe Personalized Medicines In Oncology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicines In Oncology Market Size (2020-2031)
8.2 Asia-Pacific Personalized Medicines In Oncology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2020-2025)
8.4 Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Personalized Medicines In Oncology Market Size (2020-2031)
9.2 Latin America Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Personalized Medicines In Oncology Market Size by Country (2020-2025)
9.4 Latin America Personalized Medicines In Oncology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicines In Oncology Market Size (2020-2031)
10.2 Middle East & Africa Personalized Medicines In Oncology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2020-2025)
10.4 Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biotheranostics
11.1.1 Biotheranostics Company Details
11.1.2 Biotheranostics Business Overview
11.1.3 Biotheranostics Personalized Medicines In Oncology Introduction
11.1.4 Biotheranostics Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.1.5 Biotheranostics Recent Development
11.2 Illumina
11.2.1 Illumina Company Details
11.2.2 Illumina Business Overview
11.2.3 Illumina Personalized Medicines In Oncology Introduction
11.2.4 Illumina Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.2.5 Illumina Recent Development
11.3 DNA Link
11.3.1 DNA Link Company Details
11.3.2 DNA Link Business Overview
11.3.3 DNA Link Personalized Medicines In Oncology Introduction
11.3.4 DNA Link Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.3.5 DNA Link Recent Development
11.4 Genomic Health, Inc.(Exact Sciences)
11.4.1 Genomic Health, Inc.(Exact Sciences) Company Details
11.4.2 Genomic Health, Inc.(Exact Sciences) Business Overview
11.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Introduction
11.4.4 Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.4.5 Genomic Health, Inc.(Exact Sciences) Recent Development
11.5 Cypher Genomics(Human Longevity, Inc.)
11.5.1 Cypher Genomics(Human Longevity, Inc.) Company Details
11.5.2 Cypher Genomics(Human Longevity, Inc.) Business Overview
11.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Introduction
11.5.4 Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.5.5 Cypher Genomics(Human Longevity, Inc.) Recent Development
11.6 Life Technologies Corporation(Thermo Fisher Scientific)
11.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Details
11.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
11.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Introduction
11.6.4 Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.6.5 Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
11.7 Fulgent Genetics
11.7.1 Fulgent Genetics Company Details
11.7.2 Fulgent Genetics Business Overview
11.7.3 Fulgent Genetics Personalized Medicines In Oncology Introduction
11.7.4 Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.7.5 Fulgent Genetics Recent Development
11.8 Caris Life Sciences
11.8.1 Caris Life Sciences Company Details
11.8.2 Caris Life Sciences Business Overview
11.8.3 Caris Life Sciences Personalized Medicines In Oncology Introduction
11.8.4 Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.8.5 Caris Life Sciences Recent Development
11.9 Ariana Pharma
11.9.1 Ariana Pharma Company Details
11.9.2 Ariana Pharma Business Overview
11.9.3 Ariana Pharma Personalized Medicines In Oncology Introduction
11.9.4 Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.9.5 Ariana Pharma Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Personalized Medicines In Oncology Introduction
11.10.4 Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.10.5 Abbott Laboratories Recent Development
11.11 deCODE genetics
11.11.1 deCODE genetics Company Details
11.11.2 deCODE genetics Business Overview
11.11.3 deCODE genetics Personalized Medicines In Oncology Introduction
11.11.4 deCODE genetics Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.11.5 deCODE genetics Recent Development
11.12 Exagen Inc
11.12.1 Exagen Inc Company Details
11.12.2 Exagen Inc Business Overview
11.12.3 Exagen Inc Personalized Medicines In Oncology Introduction
11.12.4 Exagen Inc Revenue in Personalized Medicines In Oncology Business (2020-2025)
11.12.5 Exagen Inc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Biotheranostics
Illumina Inc
Dna Link
Genomic Health, Inc.(Exact Sciences)
Cypher Genomics(Human Longevity, Inc.)
Life Technologies Corporation(Thermo Fisher Scientific)
Fulgent Genetics
Caris Life Sciences
Ariana Pharma
Abbott Laboratories
Decode Genetics
Exagen Inc
List of Tables
 Table 1. Global Personalized Medicines In Oncology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Molecular Oncopathology
 Table 3. Key Players of Genome Diagnostics
 Table 4. Key Players of Radiation Therapy
 Table 5. Key Players of Oncology Testing
 Table 6. Key Players of Chemotherapy
 Table 7. Key Players of Others
 Table 8. Global Personalized Medicines In Oncology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Personalized Medicines In Oncology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Personalized Medicines In Oncology Market Size by Region (2020-2025) & (US$ Million)
 Table 11. Global Personalized Medicines In Oncology Market Share by Region (2020-2025)
 Table 12. Global Personalized Medicines In Oncology Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 13. Global Personalized Medicines In Oncology Market Share by Region (2026-2031)
 Table 14. Personalized Medicines In Oncology Market Trends
 Table 15. Personalized Medicines In Oncology Market Drivers
 Table 16. Personalized Medicines In Oncology Market Challenges
 Table 17. Personalized Medicines In Oncology Market Restraints
 Table 18. Global Personalized Medicines In Oncology Revenue by Players (2020-2025) & (US$ Million)
 Table 19. Global Personalized Medicines In Oncology Market Share by Players (2020-2025)
 Table 20. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines In Oncology as of 2024)
 Table 21. Ranking of Global Top Personalized Medicines In Oncology Companies by Revenue (US$ Million) in 2024
 Table 22. Global 5 Largest Players Market Share by Personalized Medicines In Oncology Revenue (CR5 and HHI) & (2020-2025)
 Table 23. Global Key Players of Personalized Medicines In Oncology, Headquarters and Area Served
 Table 24. Global Key Players of Personalized Medicines In Oncology, Product and Application
 Table 25. Global Key Players of Personalized Medicines In Oncology, Date of Enter into This Industry
 Table 26. Mergers & Acquisitions, Expansion Plans
 Table 27. Global Personalized Medicines In Oncology Market Size by Type (2020-2025) & (US$ Million)
 Table 28. Global Personalized Medicines In Oncology Revenue Market Share by Type (2020-2025)
 Table 29. Global Personalized Medicines In Oncology Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 30. Global Personalized Medicines In Oncology Revenue Market Share by Type (2026-2031)
 Table 31. Global Personalized Medicines In Oncology Market Size by Application (2020-2025) & (US$ Million)
 Table 32. Global Personalized Medicines In Oncology Revenue Market Share by Application (2020-2025)
 Table 33. Global Personalized Medicines In Oncology Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 34. Global Personalized Medicines In Oncology Revenue Market Share by Application (2026-2031)
 Table 35. North America Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. North America Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 37. North America Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Europe Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Europe Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 40. Europe Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 41. Asia-Pacific Personalized Medicines In Oncology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2020-2025) & (US$ Million)
 Table 43. Asia-Pacific Personalized Medicines In Oncology Market Size by Region (2026-2031) & (US$ Million)
 Table 44. Latin America Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Latin America Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Latin America Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Middle East & Africa Personalized Medicines In Oncology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 48. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2020-2025) & (US$ Million)
 Table 49. Middle East & Africa Personalized Medicines In Oncology Market Size by Country (2026-2031) & (US$ Million)
 Table 50. Biotheranostics Company Details
 Table 51. Biotheranostics Business Overview
 Table 52. Biotheranostics Personalized Medicines In Oncology Product
 Table 53. Biotheranostics Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 54. Biotheranostics Recent Development
 Table 55. Illumina Company Details
 Table 56. Illumina Business Overview
 Table 57. Illumina Personalized Medicines In Oncology Product
 Table 58. Illumina Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 59. Illumina Recent Development
 Table 60. DNA Link Company Details
 Table 61. DNA Link Business Overview
 Table 62. DNA Link Personalized Medicines In Oncology Product
 Table 63. DNA Link Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 64. DNA Link Recent Development
 Table 65. Genomic Health, Inc.(Exact Sciences) Company Details
 Table 66. Genomic Health, Inc.(Exact Sciences) Business Overview
 Table 67. Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product
 Table 68. Genomic Health, Inc.(Exact Sciences) Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 69. Genomic Health, Inc.(Exact Sciences) Recent Development
 Table 70. Cypher Genomics(Human Longevity, Inc.) Company Details
 Table 71. Cypher Genomics(Human Longevity, Inc.) Business Overview
 Table 72. Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product
 Table 73. Cypher Genomics(Human Longevity, Inc.) Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 74. Cypher Genomics(Human Longevity, Inc.) Recent Development
 Table 75. Life Technologies Corporation(Thermo Fisher Scientific) Company Details
 Table 76. Life Technologies Corporation(Thermo Fisher Scientific) Business Overview
 Table 77. Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product
 Table 78. Life Technologies Corporation(Thermo Fisher Scientific) Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 79. Life Technologies Corporation(Thermo Fisher Scientific) Recent Development
 Table 80. Fulgent Genetics Company Details
 Table 81. Fulgent Genetics Business Overview
 Table 82. Fulgent Genetics Personalized Medicines In Oncology Product
 Table 83. Fulgent Genetics Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 84. Fulgent Genetics Recent Development
 Table 85. Caris Life Sciences Company Details
 Table 86. Caris Life Sciences Business Overview
 Table 87. Caris Life Sciences Personalized Medicines In Oncology Product
 Table 88. Caris Life Sciences Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 89. Caris Life Sciences Recent Development
 Table 90. Ariana Pharma Company Details
 Table 91. Ariana Pharma Business Overview
 Table 92. Ariana Pharma Personalized Medicines In Oncology Product
 Table 93. Ariana Pharma Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 94. Ariana Pharma Recent Development
 Table 95. Abbott Laboratories Company Details
 Table 96. Abbott Laboratories Business Overview
 Table 97. Abbott Laboratories Personalized Medicines In Oncology Product
 Table 98. Abbott Laboratories Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 99. Abbott Laboratories Recent Development
 Table 100. deCODE genetics Company Details
 Table 101. deCODE genetics Business Overview
 Table 102. deCODE genetics Personalized Medicines In Oncology Product
 Table 103. deCODE genetics Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 104. deCODE genetics Recent Development
 Table 105. Exagen Inc Company Details
 Table 106. Exagen Inc Business Overview
 Table 107. Exagen Inc Personalized Medicines In Oncology Product
 Table 108. Exagen Inc Revenue in Personalized Medicines In Oncology Business (2020-2025) & (US$ Million)
 Table 109. Exagen Inc Recent Development
 Table 110. Research Programs/Design for This Report
 Table 111. Key Data Information from Secondary Sources
 Table 112. Key Data Information from Primary Sources
 Table 113. Authors List of This Report


List of Figures
 Figure 1. Personalized Medicines In Oncology Picture
 Figure 2. Global Personalized Medicines In Oncology Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Personalized Medicines In Oncology Market Share by Type: 2024 VS 2031
 Figure 4. Molecular Oncopathology Features
 Figure 5. Genome Diagnostics Features
 Figure 6. Radiation Therapy Features
 Figure 7. Oncology Testing Features
 Figure 8. Chemotherapy Features
 Figure 9. Others Features
 Figure 10. Global Personalized Medicines In Oncology Market Size by Application (2020-2031) & (US$ Million)
 Figure 11. Global Personalized Medicines In Oncology Market Share by Application: 2024 VS 2031
 Figure 12. Research Centers Case Studies
 Figure 13. Governmental Institutions Case Studies
 Figure 14. Hospitals Case Studies
 Figure 15. Clinical Centers Case Studies
 Figure 16. Others Case Studies
 Figure 17. Personalized Medicines In Oncology Report Years Considered
 Figure 18. Global Personalized Medicines In Oncology Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 19. Global Personalized Medicines In Oncology Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 20. Global Personalized Medicines In Oncology Market Share by Region: 2024 VS 2031
 Figure 21. Global Personalized Medicines In Oncology Market Share by Players in 2024
 Figure 22. Global Top Personalized Medicines In Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Medicines In Oncology as of 2024)
 Figure 23. The Top 10 and 5 Players Market Share by Personalized Medicines In Oncology Revenue in 2024
 Figure 24. North America Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. North America Personalized Medicines In Oncology Market Share by Country (2020-2031)
 Figure 26. United States Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Canada Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Personalized Medicines In Oncology Market Share by Country (2020-2031)
 Figure 30. Germany Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. France Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. U.K. Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Italy Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Russia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Nordic Countries Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Personalized Medicines In Oncology Market Share by Region (2020-2031)
 Figure 38. China Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Japan Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. South Korea Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. India Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Australia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Personalized Medicines In Oncology Market Share by Country (2020-2031)
 Figure 46. Mexico Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Brazil Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Personalized Medicines In Oncology Market Share by Country (2020-2031)
 Figure 50. Turkey Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. UAE Personalized Medicines In Oncology Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. Biotheranostics Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 54. Illumina Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 55. DNA Link Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 56. Genomic Health, Inc.(Exact Sciences) Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 57. Cypher Genomics(Human Longevity, Inc.) Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 58. Life Technologies Corporation(Thermo Fisher Scientific) Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 59. Fulgent Genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 60. Caris Life Sciences Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 61. Ariana Pharma Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 62. Abbott Laboratories Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 63. deCODE genetics Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 64. Exagen Inc Revenue Growth Rate in Personalized Medicines In Oncology Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Personalized Medicine for Cancer Market Research Report 2025
Global Oncology and Cancer Treatment Drug Market Research Report 2024
Global Precision Cancer Medicine Market Research Report 2024
Personalizing Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Personalized Cancer Medicine Market Research Report 2025
Cancer Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cancer Oncology Testing Market Research Report 2024
Global Targeted Oncology Drugs Market Research Report 2024
Cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Personalized Precision Medicine Market Research Report 2024
Global Oncology Small Molecule Drugs Market Insights Forecast to 2030
Global Genomic Testing in Cancer Market Research Report 2024
Global Oncology Generic Injectable Drugs Market Research Report 2024
Precision Cancer Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oncology Anti cancer Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urological Cancer Drugs Market Research Report 2024
Global Cancer Genomic Testing Market Research Report 2024
Global Oncology Companion Diagnostic Market Research Report 2024
Oncology Based Molecular Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Precision Cancer Diagnostic Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions